PRESS RELEASE published on 02/11/2026 at 14:59, 4 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Public disclosure under Rule 8.3 of the Takeover Code on 11 Feb 2026 Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/11/2026 at 14:58, 4 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.93% ownership in Just Group plc in a Form 8.3 filing. Public position disclosure under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/11/2026 at 14:57, 4 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. files Form 8.3 for Picton Property Income Limited disclosing 5.25% ownership of relevant securities. No other party disclosures made Securities Form 8.3 Vanguard Group Ownership Disclosure Picton Property Income Limited
PRESS RELEASE published on 02/11/2026 at 14:56, 4 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.72% ownership in 1p ordinary shares of NCC Group plc as of 10 Feb 2026 Disclosure The Vanguard Group Ownership 1p Ordinary Shares NCC Group Plc
BRIEF published on 02/10/2026 at 15:14, 4 months 19 days ago Vanguard Group Discloses Stake in JTC plc Takeover Code Vanguard Group Shareholding Stake Disclosure JTC Plc
BRIEF published on 02/10/2026 at 15:14, 4 months 19 days ago Le groupe Vanguard révèle sa participation dans JTC plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Déclaration De Participation JTC Plc
BRIEF published on 02/10/2026 at 15:14, 4 months 19 days ago The Vanguard Group's Position on Avadel Pharmaceuticals plc Form 8.3 Securities Disclosure Vanguard Group Takeover Rules Avadel Pharmaceuticals
BRIEF published on 02/10/2026 at 15:14, 4 months 19 days ago Position du groupe Vanguard sur Avadel Pharmaceuticals plc Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Avadel Pharmaceuticals Règles De Rachat
BRIEF published on 02/10/2026 at 15:13, 4 months 19 days ago Vanguard Group Discloses Stake in Beazley plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Beazley Plc
BRIEF published on 02/10/2026 at 15:13, 4 months 19 days ago Vanguard Group révèle sa participation dans Beazley plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Informations Sur Les Valeurs Mobilières Beazley Plc
Published on 06/30/2026 at 00:05, 3 hours 22 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 3 hours 41 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 5 hours 26 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 12 hours 27 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 22:47, 4 hours 40 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 5 hours 22 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 5 hours 22 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 6 hours 57 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 7 hours 27 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 8 hours 57 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 8 hours 57 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 9 hours 42 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 9 hours 42 minutes ago Déclaration hebdomadaire de rachat d'actions
